Taro Appoints New Chief Financial Officer
April 10, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 10, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) announced today that Ron Kolker, C.P.A., has been appointed to the...
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
April 03, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 3, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) reported today that it has received tentative approval from the U.S....
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/ml ANDA
March 25, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., March 25, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) reported today that it has received approval from the U.S. Food and...
Taro Provides Preliminary 2007 Full Year Results
February 19, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 19, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) today provided information for the year ended December 31,...
Taro Shares to be Delisted From Nasdaq
December 12, 2006 14:31 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 12, 2006 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Nasdaq:TARO) reported today that it has received notice that the Company's ordinary...
Taro Receives ANDA Approval For Meloxicam Tablets, 7.5 mg and 15 mg, Generic Equivalent to Mobic
November 08, 2006 16:53 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 8, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug...
Taro Receives Extension of Time to File 2005 Form 20-F From Nasdaq Panel
September 13, 2006 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Sept. 13, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Nasdaq:TARO) today announced that the Nasdaq Listing Qualifications Panel (the "Panel")...
Taro Receives ANDA Approval For Extended Phenytoin Sodium Capsules, USP 100mg
September 06, 2006 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
Extended Release Capsules are Generic Equivalent to Pfizer's
Dilantin(R) Kapseals(R)
Taro's Irish Affiliate Also Received its First ANDA Approvals
...
Taro Receives Approval For Metronidazole Topical Gel USP, 0.75 Percent ANDA
July 18, 2006 14:28 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its...
Taro Receives Tentative ANDA Approvals For Carvedilol Tablets and Ondansetron HCL Tablets
April 24, 2006 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 24, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. and its affiliates and subsidiaries (Nasdaq:TARO) reported today that it has received tentative approval from the...